AzTrials
AzTrials

OsteopathyIPODENCT03382236

Evaluating the Effectiveness of Osteopathy in the Management of Pain in Elderly People

A study testing osteopathy in people with Osteopathy, run by Léa Gouaux at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This type of study can have an impact on public health policy and help improve the management of pain in people with EHPAD; Propose better use of drug treatments and non-pharmacological methods such as osteopathy; Help structuring the healthcare sector. Read more about this study

Who is it for?
Ages 75 years and older
Conditions the study is for
Osteopathy
What is being tested?
osteopathy
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
52 participants
Where
1 siteFrance
Study dates
3 Jan 2017to 31 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Patients older than 75 years
  • Patients Residing in Accommodation Facilities for Dependent Old People
  • A score measured by the DOLOPLUS 2 Scale at least 7/30 at the start of the study
  • For patients in capacity and autonomous: Patients informed and having signed a free and informed consent.
  • For non-capable patients with a trusted person and / or guardian: Informed patients whose confidant or guardian has been informed and has signed free and informed consent.
  • Affiliated to a social security scheme (beneficiary or beneficiary)

Who cannot join

  • Absence of pain
  • Medical contraindication known to the practice of osteopathy with fascial aim (advanced degenerative bone disease, metastatic cancer)
  • Osteopathic treatment in the last six months
  • Patients under curators

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Lea Gouaux

    Paris, Île-de-France Region, 77420

    Gouaux Lea, 0614315262, arc@eso-recher.fr

    Recruiting

Other trials in France

About this study

Official title: Evaluating the Effectiveness of Osteopathy in the Management of Pain in Elderly People in Residential Care Facilities for the Elderly (EHPAD)

This type of study can have an impact on public health policy and help improve the management of pain in people with EHPAD; Propose better use of drug treatments and non-pharmacological methods such as osteopathy; Help structuring the healthcare sector.

Read the detailed description
  • "Osteopathy" group: 3 osteopathy sessions of 45 min with one session every 3 weeks at S2, S5 and S8. Fascial osteopathic techniques performed will consist of gentle and non-impulsive manipulation
  • "Simulated" group: 3 simulated osteopathy sessions lasting 45 minutes, one session every 3 weeks at S2, S5 and S8. The techniques performed will consist of an application of the hands to different anatomical regions than the group "osteopathy" without therapeutic intention, that is to say without tissue tensioning.

The pain will be assessed at inclusion (S0) and at the end of the procedure (S12) by the head physician, the coordinating physician or the psychomotor therapist, ignoring the assignment group of the subject and before each session. osteopathy (at S2, S5 and S8) by a nurse or psychomotor also ignoring the patient's assignment group.

Both groups will continue to benefit from their usual allopathic management and recommendations.

Patients will not be aware of the treatment received (osteopathy or simulated) and will be randomized by a computer server.

Conditions
Osteopathy
Being tested
osteopathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • osteopathyOther

    osteopathic techniques

Study groups in NCT03382236
Study groupRoleWhat they receive
Real osteopathyExperimentalNot described
Receives: Other: osteopathy
Sham osteopathyPlacebo comparatorNot described
Receives: Other: osteopathy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. DOLOPLUS 2 score

    Assessment of pain assessed by the behavioral scale

    Measured: Every week after inclusion during 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2017
  2. Study start3 Jan 2017
  3. Primary completion31 Dec 2018 (estimated)
  4. Study completion31 Dec 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03382236
Sponsor's protocol ID
BTP RMS
Acronym
IPODE
Status last verified
Dec 2017
First submitted
11 Dec 2017
Last updated
22 Dec 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing osteopathy in people with Osteopathy, run by Léa Gouaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

DOLOPLUS 2 score (time frame: Every week after inclusion during 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in